Affini-T is developing specific TCR-based immunotherapies for solid tumors using two complementary therapeutic modalities
Latest News
01.07.2024
Affini-T Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
Press Releases
01.07.2024
Affini-T Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
Press Releases